AGTC

10 Decision Makers · 10 Verified Contacts

📍 Alachua, Florida, United StatesBiotechnology🗓 Est. 1999👥 101–250 employees

About AGTC

AGTC is a biotechnology company conducting human clinical trials of AAV-based gene therapies for the treatment of rare diseases.

Leadership & Decision Makers

Contact details of 10 AGTC decision makers

Scott Koenig

Chairman of the Board of Directors

Sue Washer

President & CEO

Terence Flotte

Founder

R. Jude Samulski

Founder

Barry Byrne

Founder

William A. Sullivan

Chief Financial Officer

Mark S.Shearman

Chief Scientific Officer

Larry Bullock

Chief Financial Officer

Nicholas Muzyczka

Founder

William Hauswirth

Founder

General Emails

General company emails, e.g. customer support lines

    webmaster@agtc.com

    Unclassified inbox

    swasher@agtc.com

    Unclassified inbox

    jchulay@agtc.com

    Unclassified inbox

    potter@agtc.com

    Unclassified inbox

    tracanelli@agtc.com

    Unclassified inbox

    nspotter@agtc.com

    Unclassified inbox

Similar Companies like AGTC

Sorrento Therapeutics

sorrentotherapeutics.com
Pharmaceuticals · San Diego, CA · Est. 2006 · 101–250 employees · $500M–$1B

HQ: San Diego, CA

Jazz Pharmaceuticals

jazzpharma.com
Biotechnology · Palo Alto, CA · Est. 2003 · 501–1000 employees · $500M–$1B

HQ: Palo Alto, CA

Moderna

modernatx.com
Biotechnology · Cambridge, MA · Est. 2010 · 1001–5000 employees

HQ: Cambridge, MA

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Biotechnology · Boston, MA · Est. 1989 · 1001–5000 employees · $500M–$1B

HQ: Boston, MA

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 14/07/2025

+1 386-462-2204

Alachua, Florida, United States

Specialization: Clinical Trials, Genetics,
Legal Name: Applied Genetic Technologies Corporation
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Founded Date: 1999
Company Type: For Profit
Stock Symbol: NASDAQ:AGTC
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: +1 386-462-2204
Last Investment Activity: Nov 22, 2022
Investments Activity: Nov 22, 2022 Nov 17, 2022 Oct 27, 2022

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.